ホームニュースプライマリ・ケア領域で役立つエビデンスNo.78：重症肺炎ステロイドとニキビのスピロノラクトン【Podcast：にゃんごう＆いがさんのEBMerな夜】
ニュース
プライマリ・ケア領域で役立つエビデンス
No.78：重症肺炎ステロイドとニキビのスピロノラクトン【Podcast：にゃんごう＆いがさんのEBMerな夜】
にゃんごう＆いがさんのEBMerな夜
第78回放送 2023/5/29
【にゃんごう：重症肺炎ステロイド】
Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, Reignier J, Heming N, Plantefeve G, Souweine B, Voiriot G, Colin G, Frat JP, Mira JP, Barbarot N, Francois B, Louis G, Gibot S, Guitton C, Giacardi C, Hraiech S, Vimeux S, L’Her E, Faure H, Herbrecht JE, Bouisse C, Joret A, Terzi N, Gacouin A, Quentin C, Jourdain M, Leclerc M, Coffre C, Bourgoin H, Lengelle C, Caille-Fenerol C, Giraudeau B, Le Gouge A; CRICS-TriGGERSep Network.
Hydrocortisone in Severe Community-Acquired Pneumonia.
N Engl J Med. 2023 May 25;388(21):1931-1941. doi: 10.1056/NEJMoa2215145. Epub 2023 Mar 21.
PMID: 36942789.
https://www.nejm.org/doi/full/10.1056/NEJMoa2215145
【いがさん：ニキビのスピロノラクトン】
Santer M, Lawrence M, Renz S, Eminton Z, Stuart B, Sach TH, Pyne S, Ridd MJ, Francis N, Soulsby I, Thomas K, Permyakova N, Little P, Muller I, Nuttall J, Griffiths G, Thomas KS, Layton AM; SAFA trial investigators.
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial.
BMJ. 2023 May 16;381:e074349. doi: 10.1136/bmj-2022-074349.
PMID: 37192767.
https://www.bmj.com/content/381/bmj-2022-074349
リスナーアンケートにご協力下さい！！
https://goo.gl/forms/5AsPilK7QnB9VrmX2
第78回放送 2023/5/29
【にゃんごう：重症肺炎ステロイド】
Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, Reignier J, Heming N, Plantefeve G, Souweine B, Voiriot G, Colin G, Frat JP, Mira JP, Barbarot N, Francois B, Louis G, Gibot S, Guitton C, Giacardi C, Hraiech S, Vimeux S, L’Her E, Faure H, Herbrecht JE, Bouisse C, Joret A, Terzi N, Gacouin A, Quentin C, Jourdain M, Leclerc M, Coffre C, Bourgoin H, Lengelle C, Caille-Fenerol C, Giraudeau B, Le Gouge A; CRICS-TriGGERSep Network.
Hydrocortisone in Severe Community-Acquired Pneumonia.
N Engl J Med. 2023 May 25;388(21):1931-1941. doi: 10.1056/NEJMoa2215145. Epub 2023 Mar 21.
PMID: 36942789.
https://www.nejm.org/doi/full/10.1056/NEJMoa2215145
【いがさん：ニキビのスピロノラクトン】
Santer M, Lawrence M, Renz S, Eminton Z, Stuart B, Sach TH, Pyne S, Ridd MJ, Francis N, Soulsby I, Thomas K, Permyakova N, Little P, Muller I, Nuttall J, Griffiths G, Thomas KS, Layton AM; SAFA trial investigators.
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial.
BMJ. 2023 May 16;381:e074349. doi: 10.1136/bmj-2022-074349.
PMID: 37192767.
https://www.bmj.com/content/381/bmj-2022-074349
リスナーアンケートにご協力下さい！！
https://goo.gl/forms/5AsPilK7QnB9VrmX2
最終更新：2023年05月30日 13時07分
